Healio

Icosapent ethyl appropriate to use to reduce CV risk, despite pending questions

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Findings of cardiovascular benefit with icosapent ethyl treatment from the REDUCE-IT trial have ...
Healio

Icosapent ethyl appears to reduce inflammation, improve symptoms in COVID-19

Please provide your email address to receive an email when new articles are posted on . For the open-label COVID-19 Cardiolink-9 study, the researchers randomly assigned 100 symptomatic patients with ...
The American Journal of Managed Care

Implications for Treating Patients With Icosapent Ethyl

Health care professionals consider how to adopt data demonstrated by trials such as REDUCE-IT into clinical practice when considering icosapent ethyl as treatment for patients with diabetes.
TCTMD

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

PHILADELPHIA, PA—Preliminary data suggest that icosapent ethyl (Vascepa; Amarin) slows the progression of atherosclerosis in patients similar to those enrolled in the REDUCE-IT trial, which showed a ...
Yahoo Finance

VASCEPA® (icosapent ethyl) Data from REDUCE-IT® REVASC, Including New Data on Timeframe to Demonstrated Benefit, Presented as Encore at The American Society for Preventive ...

DUBLIN, Ireland and BRIDGEWATER, N.J., July 27, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that data from the REDUCE-IT® REVASC analysis, presented as an encore by ...
TCTMD

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Much like in the overall REDUCE-IT trial, icosapent ethyl (Vascepa; Amarin) reduced a broad range of adverse clinical outcomes in the large subgroup of patients who had undergone a prior PCI, a ...
MedPage Today

Icosapent Ethyl Linked to Reduced Risk of Cardiovascular Events

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Use of icosapent ethyl (Vascepa), a highly purified ...
Monthly Prescribing Reference

Icosapent Ethyl Significantly Lowers Triglycerides Without Raising LDL-C

The ANCHOR study was not designed to determine effects on hsCRP or CV events. Among statin-treated patients with persistent high triglycerides (TG 200–499mg/dL) and elevated high-sensitivity ...
Monthly Prescribing Reference

Case Series Describes Use of Icosapent Ethyl for COVID-19 Pneumonia

The authors described the cases of 3 patients with moderate to severe COVID-19 pneumonia who were treated with 2g of icosapent ethyl administered twice daily via a nasogastric tube. The use of ...
Business Wire

Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) and Strides Pharma Science Limited (“Strides”) today announced the addition of Icosapent ethyl ...
Yahoo Finance

Fifteen Medical Societies Now Recommend Icosapent Ethyl to Reduce Cardiovascular Risk, Further Supporting that VASCEPA® is Rapidly Becoming a New Standard of Care

DUBLIN, Ireland and BRIDGEWATER, N.J., March 29, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the Canadian Cardiovascular Society (CCS) and the Egyptian Heart ...
Medindia

Side effect(s) of Icosapent Ethyl

Review the side-effects of Icosapent Ethyl as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...